Form 4: AbbVie Director Acquires Stock Equivalent Units Through Fees

Director Susan E. Quaggin acquired 71 stock equivalent units of AbbVie Inc. through director fees credited to a grantor trust.

Summary

• On March 31, 2025, Susan E. Quaggin, a director of AbbVie Inc., acquired 71 stock equivalent units.
• The acquisition was a result of director fees credited to a stock equivalent unit account under a grantor trust.
• The price per unit was $209.52.
• Following the transaction, Quaggin directly owns 476 stock equivalent units.
• These units earn the same return as if the fees were invested in AbbVie stock and are generally paid in cash at age 65 or upon retirement from the board.
• The balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The director's acquisition of stock equivalent units indicates confidence in the company's future, but it's a routine transaction.

Positives

• The director's acquisition of stock equivalent units demonstrates confidence in AbbVie's future performance.
• The dividend reinvestment feature further increases the director's stake in the company.

Future Outlook

The stock equivalent units are generally paid in cash at age 65 or upon retirement from the board.

Industry Context

Directors often receive compensation in the form of stock or stock equivalent units to align their interests with those of shareholders. This Form 4 filing is a routine disclosure of such transactions.

Related Party Transactions

• The acquisition of stock equivalent units by the director is a related party transaction as it involves compensation for services provided to the company.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with theirs.

Key Dates

Keywords

AbbVie, Director, Stock Equivalent Units, Form 4, Beneficial Ownership, ABBV, Quaggin